Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $5.01 USD
Change Today +0.01 / 0.20%
Volume 1.7M
OREX On Other Exchanges
Symbol
Exchange
NASDAQ GS
As of 8:10 PM 05/22/15 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for orexigen therapeutics inc (OREX)

Year over year, Orexigen Therapeutics, Inc. has been able to grow revenues from $3.4M USD to $55.5M USD. Most impressively, the company has been able to reduce the percentage of sales devoted to cost of goods sold from 1,655.43% to 84.60%. This was a driver that led to an improvement in the bottom line from a loss of $77.7M USD to a smaller loss of $37.5M USD.
Currency in
Millions of US Dollars
As of:Dec 31
2011
Reclassified
Dec 31
2012
Reclassified
Dec 31
2013
Reclassified
Dec 31
2014
4 Year
Trend
Revenues4.43.43.455.5
TOTAL REVENUES4.43.43.455.5
Cost of Goods Sold10.273.756.747.0
GROSS PROFIT-5.8-70.3-53.38.5
Selling General & Admin Expenses, Total18.120.023.928.6
R&D Expenses------10.4
OTHER OPERATING EXPENSES, TOTAL18.120.023.939.1
OPERATING INCOME-23.9-90.2-77.2-30.5
Interest Expense-0.20.0-0.5-7.1
Interest and Investment Income0.00.10.10.1
NET INTEREST EXPENSE-0.20.1-0.5-7.0
EBT, EXCLUDING UNUSUAL ITEMS-24.1-90.1-77.7-37.5
Merger & Restructuring Charges-4.0------
EBT, INCLUDING UNUSUAL ITEMS-28.1-90.1-77.7-37.5
Earnings from Continuing Operations-28.1-90.1-77.7-37.5
NET INCOME-28.1-90.1-77.7-37.5
NET INCOME TO COMMON INCLUDING EXTRA ITEMS-28.1-90.1-77.7-37.5
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS-28.1-90.1-77.7-37.5
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
OREX:US $5.01 USD +0.01

OREX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Arena Pharmaceuticals Inc $4.19 USD -0.01
GlaxoSmithKline PLC 1,465 GBp +14.00
Novo Nordisk A/S kr388.00 DKK +3.50
VIVUS Inc $2.53 USD -0.05
View Industry Companies
 

Industry Analysis

OREX

Industry Average

Valuation OREX Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 10.5x
Price/Book 51.1x
Price/Cash Flow NM Not Meaningful
TEV/Sales 6.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact OREXIGEN THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.